Skip to main content

Table 4 The evaluation of additive interaction for the prevention of therapeutic duplication or drug interaction

From: Identification of individuals benefiting from the kakaritsuke-yakuzaishi (family pharmacist) system in Japan: a retrospective cohort study using an employment-based health insurance claims database

Variables

Levels

Non-user

User

aARDs of product terms (95% CIs)

Age

 < 60 years

REF

2.1

-0.8 (-4.4 to 2.8)

 ≥ 60 years

0.5

1.8

Sex

Male

REF

-0.2

4.7 (1.6 to 7.9)

Female

0.5

5.1

Types of drugs

 < 6

REF

-1.0

4.4 (1.7 to 7.1)

 ≥ 6

0.0

3.4

Medical institutions used

 < 2

REF

-0.9

4.5 (1.8 to 7.3)

 ≥ 2

-0.1

3.5

Use of multiple departments in a hospital

No

REF

1.4

7.0 (-0.5 to 14.5)

Yes

2.2

10.6

Admission

No

REF

1.7

4.1 (-4.2 to 12.4)

Yes

0.5

6.2

Use of one-dose package for drugs

No

REF

1.6

5.9 (-2.4 to 14.1)

Yes

1.8

9.2

Antihypertensives

No

REF

1.7

0.5 (-2.8 to 3.7)

Yes

0.0

2.2

Antilipidemic agents

No

REF

2.2

-1.3 (-4.6 to 2.1)

Yes

0.4

1.4

Antidiabetic agents other than insulin

No

REF

1.6

2.6 (-2.7 to 7.9)

Yes

0.6

4.7

Insulin

No

REF

1.6

14.6 (-1.6 to 30.8)

Yes

1.1

17.3

Anticoagulants

No

REF

1.7

6.0 (-6.9 to 18.9)

Yes

0.5

8.2

Antiplatelet agents

No

REF

1.9

0.4 (-7.4 to 8.1)

Yes

-0.3

2.0

Proton pump inhibitors

No

REF

1.1

5.8 (0.7 to 10.8)

Yes

1.7

8.6

H2 blockers

No

REF

1.8

0.7 (-5.7 to 7.0)

Yes

1.4

3.9

H1 blockers

No

REF

0.9

3.1 (-0.3 to 6.6)

Yes

0.7

4.7

Antipsychotics

No

REF

1.6

2.3 (-3.1 to 7.7)

Yes

0.4

4.3

BZDs/Non-BZDs

No

REF

1.1

3.6 (-0.5 to 7.7)

Yes

0.5

5.2

Antidepressants

No

REF

2.0

-0.9 (-5.4 to 3.7)

Yes

0.0

1.1

Antibiotics

No

REF

0.0

5.5 (2.0 to 9.0)

Yes

0.0

5.6

NSAIDs

No

REF

1.5

1.0 (-2.2 to 4.3)

Yes

0.3

2.8

Steroids

No

REF

1.4

5.0 (-1.2 to 11.1)

Yes

0.8

7.1

Probiotics

No

REF

0.8

8.0 (2.4 to 13.5)

Yes

0.3

9.1

Laxatives

No

REF

1.7

3.6 (-4.2 to 11.3)

Yes

0.4

5.7

Vitamins

No

REF

1.7

2.4 (-3.4 to 8.1)

Yes

0.7

4.7

Traditional Japanese herbal medicines

No

REF

0.5

7.0 (2.5 to 11.5)

Yes

0.5

8.0

  1. Abbreviations: aARDs adjusted Absolute Risk Differences, BZDs Benzodiazepine, CIs Confidence Intervals, NSAIDs Non-steroidal Anti-inflammatory Drugs, REF Reference
  2. Value in each stratum indicates aARDs from a common REF stratum